These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 23884639)

  • 41. Androgen signaling is a confounding factor for β-catenin-mediated prostate tumorigenesis.
    Lee SH; Luong R; Johnson DT; Cunha GR; Rivina L; Gonzalgo ML; Sun Z
    Oncogene; 2016 Feb; 35(6):702-14. PubMed ID: 25893287
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stage-specific alterations of DNA methyltransferase expression, DNA hypermethylation, and DNA hypomethylation during prostate cancer progression in the transgenic adenocarcinoma of mouse prostate model.
    Morey Kinney SR; Smiraglia DJ; James SR; Moser MT; Foster BA; Karpf AR
    Mol Cancer Res; 2008 Aug; 6(8):1365-74. PubMed ID: 18667590
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Loss of MyD88 leads to more aggressive TRAMP prostate cancer and influences tumor infiltrating lymphocytes.
    Peek EM; Song W; Zhang H; Huang J; Chin AI
    Prostate; 2015 Apr; 75(5):463-73. PubMed ID: 25597486
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Selective expression of myosin IC Isoform A in mouse and human cell lines and mouse prostate cancer tissues.
    Ihnatovych I; Sielski NL; Hofmann WA
    PLoS One; 2014; 9(9):e108609. PubMed ID: 25259793
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dysfunctional transforming growth factor-beta receptor II accelerates prostate tumorigenesis in the TRAMP mouse model.
    Pu H; Collazo J; Jones E; Gayheart D; Sakamoto S; Vogt A; Mitchell B; Kyprianou N
    Cancer Res; 2009 Sep; 69(18):7366-74. PubMed ID: 19738062
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prostate cancer chemoprevention by sulforaphane in a preclinical mouse model is associated with inhibition of fatty acid metabolism.
    Singh KB; Kim SH; Hahm ER; Pore SK; Jacobs BL; Singh SV
    Carcinogenesis; 2018 May; 39(6):826-837. PubMed ID: 29668854
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model.
    Raina K; Rajamanickam S; Singh RP; Deep G; Chittezhath M; Agarwal R
    Cancer Res; 2008 Aug; 68(16):6822-30. PubMed ID: 18701508
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stromal activation associated with development of prostate cancer in prostate-targeted fibroblast growth factor 8b transgenic mice.
    Elo TD; Valve EM; Seppänen JA; Vuorikoski HJ; Mäkelä SI; Poutanen M; Kujala PM; Härkönen PL
    Neoplasia; 2010 Nov; 12(11):915-27. PubMed ID: 21076617
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.
    Henrique R; Jerónimo C; Hoque MO; Carvalho AL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
    DNA Cell Biol; 2005 Apr; 24(4):264-9. PubMed ID: 15812243
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nuclear matrix localization of high mobility group protein I(Y) in a transgenic mouse model for prostate cancer.
    Leman ES; Madigan MC; Brünagel G; Takaha N; Coffey DS; Getzenberg RH
    J Cell Biochem; 2003 Feb; 88(3):599-608. PubMed ID: 12532335
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phellodendron amurense bark extract prevents progression of prostate tumors in transgenic adenocarcinoma of mouse prostate: potential for prostate cancer management.
    Ghosh R; Graham H; Rivas P; Tan XJ; Crosby K; Bhaskaran S; Schoolfield J; Banu J; Fernandes G; Yeh IT; Kumar AP
    Anticancer Res; 2010 Mar; 30(3):857-65. PubMed ID: 20393007
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential expression of αVβ3 and αVβ6 integrins in prostate cancer progression.
    Quaglia F; Krishn SR; Wang Y; Goodrich DW; McCue P; Kossenkov AV; Mandigo AC; Knudsen KE; Weinreb PH; Corey E; Kelly WK; Languino LR
    PLoS One; 2021; 16(1):e0244985. PubMed ID: 33481853
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cooperation between FGF8b overexpression and PTEN deficiency in prostate tumorigenesis.
    Zhong C; Saribekyan G; Liao CP; Cohen MB; Roy-Burman P
    Cancer Res; 2006 Feb; 66(4):2188-94. PubMed ID: 16489020
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Murine prostate cancer inhibition by dietary phytochemicals--curcumin and phenyethylisothiocyanate.
    Barve A; Khor TO; Hao X; Keum YS; Yang CS; Reddy B; Kong AN
    Pharm Res; 2008 Sep; 25(9):2181-9. PubMed ID: 18437538
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A mouse model of heterogeneous, c-MYC-initiated prostate cancer with loss of Pten and p53.
    Kim J; Roh M; Doubinskaia I; Algarroba GN; Eltoum IE; Abdulkadir SA
    Oncogene; 2012 Jan; 31(3):322-32. PubMed ID: 21685943
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells.
    Iwata T; Schultz D; Hicks J; Hubbard GK; Mutton LN; Lotan TL; Bethel C; Lotz MT; Yegnasubramanian S; Nelson WG; Dang CV; Xu M; Anele U; Koh CM; Bieberich CJ; De Marzo AM
    PLoS One; 2010 Feb; 5(2):e9427. PubMed ID: 20195545
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression pattern of mouse homolog of prostate-specific membrane antigen (FOLH1) in the transgenic adenocarcinoma of the mouse prostate model.
    Schmittgen TD; Zakrajsek BA; Hill RE; Liu Q; Reeves JJ; Axford PD; Singer MJ; Reed MW
    Prostate; 2003 Jun; 55(4):308-16. PubMed ID: 12712410
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adenocarcina of the mouse prostate growth inhibition by celecoxib: downregulation of transcription factors involved in COX-2 inhibition.
    Narayanan BA; Narayanan NK; Pttman B; Reddy BS
    Prostate; 2006 Feb; 66(3):257-65. PubMed ID: 16175586
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Murine six-transmembrane epithelial antigen of the prostate, prostate stem cell antigen, and prostate-specific membrane antigen: prostate-specific cell-surface antigens highly expressed in prostate cancer of transgenic adenocarcinoma mouse prostate mice.
    Yang D; Holt GE; Velders MP; Kwon ED; Kast WM
    Cancer Res; 2001 Aug; 61(15):5857-60. PubMed ID: 11479226
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
    Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
    Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.